Large granular lymphocyte leukemia: from dysregulated pathways to therapeutic targets
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Large granular lymphocyte leukemia: from dysregulated pathways to therapeutic targets
Authors
Keywords
-
Journal
Future Oncology
Volume 8, Issue 7, Pages 787-801
Publisher
Future Medicine Ltd
Online
2012-07-25
DOI
10.2217/fon.12.75
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Targeting Sphingosine-1-Phosphate Receptors in Cancer
- (2012) Rebecca J. Watters et al. Anti-Cancer Agents in Medicinal Chemistry
- SomaticSTAT3Mutations in Large Granular Lymphocytic Leukemia
- (2012) Hanna L.M. Koskela et al. NEW ENGLAND JOURNAL OF MEDICINE
- Alkylation of Cysteine 468 in Stat3 Defines a Novel Site for Therapeutic Development
- (2011) Ralf Buettner et al. ACS Chemical Biology
- Therapeutic efficacy of FTY720 in a rat model of NK-cell leukemia
- (2011) A. Liao et al. BLOOD
- Increased serum soluble IL-15R levels in T-cell large granular lymphocyte leukemia
- (2011) J. Chen et al. BLOOD
- Roles of the Ras/Raf/MEK/ERK pathway in leukemia therapy
- (2011) L S Steelman et al. LEUKEMIA
- T-cell and natural killer-cell large granular lymphocyte leukemia neoplasias
- (2011) Rebecca J. Watters et al. LEUKEMIA & LYMPHOMA
- Targeting of survivin by nanoliposomal ceramide induces complete remission in a rat model of NK-LGL leukemia
- (2010) X. Liu et al. BLOOD
- How I treat LGL leukemia
- (2010) T. Lamy et al. BLOOD
- FTY720 Shows Promising In vitro and In vivo Preclinical Activity by Downmodulating Cyclin D1 and Phospho-Akt in Mantle Cell Lymphoma
- (2010) Q. Liu et al. CLINICAL CANCER RESEARCH
- Oral Therapies for Multiple Sclerosis
- (2010) Ralf Gold CNS DRUGS
- Targeted Blockage of Signal Transducer and Activator of Transcription 5 Signaling Pathway with Decoy Oligodeoxynucleotides Suppresses Leukemic K562 Cell Growth
- (2010) Xiaozhong Wang et al. DNA AND CELL BIOLOGY
- Farnesyltransferase inhibitors: where are we now?
- (2010) Apostolia Maria Tsimberidou et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- The PI3K Pathway As Drug Target in Human Cancer
- (2010) Kevin D. Courtney et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase I study of bortezomib combined with chemotherapy in children with relapsed childhood acute lymphoblastic leukemia (ALL): A report from the therapeutic advances in childhood leukemia (TACL) consortium
- (2010) Yoav Messinger et al. PEDIATRIC BLOOD & CANCER
- T Cell Activation
- (2009) Jennifer E. Smith-Garvin et al. Annual Review of Immunology
- Platelet-derived growth factor mediates survival of leukemic large granular lymphocytes via an autocrine regulatory pathway
- (2009) J. Yang et al. BLOOD
- Interleukin-15 Enhances Proteasomal Degradation of Bid in Normal Lymphocytes: Implications for Large Granular Lymphocyte Leukemias
- (2009) D. L. Hodge et al. CANCER RESEARCH
- Phase I Trial of Oral Irinotecan and Temozolomide for Children With Relapsed High-Risk Neuroblastoma: A New Approach to Neuroblastoma Therapy Consortium Study
- (2009) Lars M. Wagner et al. JOURNAL OF CLINICAL ONCOLOGY
- KRAS Mutations and Sensitivity to Epidermal Growth Factor Receptor Inhibitors in Colorectal Cancer: Practical Application of Patient Selection
- (2009) Antonio Jimeno et al. JOURNAL OF CLINICAL ONCOLOGY
- The life of a cell: apoptosis regulation by the PI3K/PKB pathway
- (2008) Vincent Duronio BIOCHEMICAL JOURNAL
- Clinical improvement by farnesyltransferase inhibition in NK large granular lymphocyte leukemia associated with imbalanced NK receptor signaling
- (2008) P. K. Epling-Burnette et al. BLOOD
- Molecular profiling of LGL leukemia reveals role of sphingolipid signaling in survival of cytotoxic lymphocytes
- (2008) M. V. Shah et al. BLOOD
- A selective sphingosine kinase 1 inhibitor integrates multiple molecular therapeutic targets in human leukemia
- (2008) S. W. Paugh et al. BLOOD
- Growth inhibition of human hepatocellular carcinoma cells by blocking STAT3 activation with decoy-ODN
- (2008) Xiaoxia Sun et al. CANCER LETTERS
- Superior Activity of Fusion Protein scFvRit:sFasL over Cotreatment with Rituximab and Fas Agonists
- (2008) E. Bremer et al. CANCER RESEARCH
- Targeting the PI3K/Akt/mTOR pathway: Effective combinations and clinical considerations
- (2008) J LOPICCOLO et al. DRUG RESISTANCE UPDATES
- Targeting STAT3 in cancer: how successful are we?
- (2008) Peibin Yue et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Lipid signalling in disease
- (2008) Matthias P. Wymann et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Network model of survival signaling in large granular lymphocyte leukemia
- (2008) R. Zhang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search